Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very rapid, large-scale, and low-cost production of vaccines that could potentially be used to protect people when there is a pandemic.
Mynvax, which was incubated at the Indian Institute of Science, was founded in2017 by Raghavan Varadarajan and Gautham Nadig.